TY  - GEN
AU  - Skarlos,P
AU  - Christodoulou,C
AU  - Kalogeras,K T
AU  - Eleftheraki,A G
AU  - Bobos,M
AU  - Batistatou,A
AU  - Valavanis,C
AU  - Tzaida,O
AU  - Timotheadou,E
AU  - Kronenwett,R
AU  - Wirtz,R M
AU  - Kostopoulos,I
AU  - Televantou,D
AU  - Koutselini,E
AU  - Papaspirou,I
AU  - Papadimitriou,C A
AU  - Pectasides,D
AU  - Gogas,H
AU  - Aravantinos,G
AU  - Pavlidis,N
AU  - Arapantoni,P
AU  - Skarlos,D V
AU  - Fountzilas,G
TI  - Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial
SN  - 1432-0843
PY  - 2012///0320
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Chemotherapy, Adjuvant
KW  - Clinical Trials, Phase III as Topic
KW  - Cluster Analysis
KW  - Disease-Free Survival
KW  - Dose-Response Relationship, Drug
KW  - Estrogen Receptor alpha
KW  - genetics
KW  - Estrogen Receptor beta
KW  - Female
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Immunohistochemistry
KW  - Middle Aged
KW  - Outcome Assessment, Health Care
KW  - methods
KW  - Phenotype
KW  - Prognosis
KW  - Randomized Controlled Trials as Topic
KW  - Receptor, ErbB-2
KW  - Receptors, Estrogen
KW  - Receptors, Progesterone
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Translational Research, Biomedical
KW  - Young Adult
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s00280-011-1730-9
ER  -